Cited by 482Pluripotent Stem Cells ResearchAlzheimer's disease research and treatmentsNeurogenesis and neuroplasticity mechanisms

The DOI matches its Crossref record; 234 of the 235 references it cites were found in a registry or an index.

Modeling Alzheimer’s disease with iPSC-derived brain cells

Open access

Penney, Jay, Ralvenius, William T., Tsai, Li-Huei·2020·Molecular Psychiatry

DOI 10.1038/s41380-019-0468-3PMC PMC6906186

Open this paper in CoChat — free account Open PDF

Abstract

Alzheimer's disease is a devastating neurodegenerative disorder with no cure. Countless promising therapeutics have shown efficacy in rodent Alzheimer's disease models yet failed to benefit human patients. While hope remains that earlier intervention with existing therapeutics will improve outcomes, it is becoming increasingly clear that new approaches to understand and combat the pathophysiology of Alzheimer's disease are needed. Human induced pluripotent stem cell (iPSC) technologies have changed the face of preclinical research and iPSC-derived cell types are being utilized to study an array of human conditions, including neurodegenerative disease. All major brain cell types can now be differentiated from iPSCs, while increasingly complex co-culture systems are being developed to facilitate neuroscience research. Many cellular functions perturbed in Alzheimer's disease can be recapitulated using iPSC-derived cells in vitro, and co-culture platforms are beginning to yield insights into the complex interactions that occur between brain cell types during neurodegeneration. Further, iPSC-based systems and genome editing tools will be critical in understanding the roles of the numerous new genes and mutations found to modify Alzheimer's disease risk in the past decade. While still in their relative infancy, these developing iPSC-based technologies hold considerable promise to push forward efforts to combat Alzheimer's disease and other neurodegenerative disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41380-019-0468-3

Cites

234 of 234 references verified0 citation errors · 0 not checkable

Statistics

Fig. 1 Brain cell types in Alzheimer’s disease. A summary of the major human brain cell types and the alterations they exhibit in ADCC BY · PubMed Central

Fig. 2 Human iPSC differentiation to brain cell types. Somatic cells from patients or healthy individuals can be reprogrammed to iPSCs and subsequently differentiated into all major brain cell types for in vitro studies. Such studies can examine cellular functions as well as how they are impacted by AD hallmark pathologies or AD-linked mutations. Genome editing techniques can be used to introduce or correct AD-linked mutations to examine phenotypes in isogenic backgrounds. 3D and co-culture models allow for examination of interactions occurring between cell types and sub-types to better model processes occurring in vivo. These and developing techniques hold promise for better understanding the relevant pathomechanisms underlying AD, and will hopefully facilitate development of effective therapeutics to combat dementiaCC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Cerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017

Show all 235 references

Sorted by citations

Items 101–200 of 482

Microglia: roles and genetic risk in Parkinson’s disease
Trainor, A. R., MacDonald, D. S., & Penney, J. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1506358 · Cited by 34
Self-citation
3D bioprinting approaches for enhancing stem cell-based neural tissue regeneration
Bektas, C. K., Luo, J., Conley, B., Le, K.-P. N., & Lee, K. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.01.006 · Cited by 35
Alzheimer’s disease: a tale of two diseases?
Nardini, E., Hogan, R., Flamier, A., & Bernier, G. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.308070 · Cited by 33
Native PLGA nanoparticles regulate APP metabolism and protect neurons against β-amyloid toxicity: Potential significance in Alzheimer's disease pathology
Wu, Q., Karthivashan, G., Nakhaei‐Nejad, M., Anand, B. G., Giuliani, F., & Kar, S. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.08.148 · Cited by 30
The Impact of the Cellular Environment and Aging on Modeling Alzheimer's Disease in 3D Cell Culture Models
Hebisch, M., Klostermeier, S., Wolf, K., Boccaccini, A. R., Wolf, S. E., Tanzi, R. E., & Kim, D. Y. (2023) · Advanced Science · doi:10.1002/advs.202205037 · Cited by 31
iPSC-derived hindbrain organoids to evaluate escitalopram oxalate treatment responses targeting neuropsychiatric symptoms in Alzheimer’s disease
Zivko, C., Sagar, R., Xydia, A., López-Montes, A., Mintzer, J. E., Rosenberg, P. B., Shade, D. M., Porsteinsson, A. P., Lyketsos, C. G., & Mahairaki, V. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02629-y · Cited by 30
Emerging hiPSC Models for Drug Discovery in Neurodegenerative Diseases
Trudler, D., Ghatak, S., & Lipton, S. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158196 · Cited by 30
Neural Stem Cells in the Treatment of Alzheimer’s Disease: Current Status, Challenges, and Future Prospects
Chen, X., Jiang, S., Wang, R., Bao, X., & Li, Y. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220721 · Cited by 34
APOE3 Christchurch modulates β-catenin/Wnt signaling in iPS cell-derived cerebral organoids from Alzheimer’s cases
Perez-Corredor, P., Vanderleest, T. E., Vacano, G. N., Sanchez, J. S., Villalba-Moreno, N. D., Marino, C., Krasemann, S., Mendivil-Perez, M. A., Aguillón, D., Jiménez-Del-Río, M., et al. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1373568 · Cited by 28
“While it is well documented that iPS cell systems can model aspects of AD pathology (Penney et al., 2020; Nelson et al., 2023), we have also demonstrated here that the iPS system is also capable of accurately identifying cellular processes differentially regulated by the APOE3Ch variant.”
Background
Advances in the Understanding of the Correlation Between Neuroinflammation and Microglia in Alzheimer’s Disease
Yan, H., Wang, W., Cui, T., Shao, Y., Li, M., Fang, L., & Feng, L. (2024) · ImmunoTargets and Therapy · doi:10.2147/itt.s455881 · Cited by 32
A framework for translating tauopathy therapeutics: Drug discovery to clinical trials
Feldman, H., Cummings, J. L., Boxer, A. L., Staffaroni, A. M., Knopman, D. S., Rizzo, S. J. S., Territo, P. R., Arnold, S. E., Ballard, C. G., Beher, D., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14250 · Cited by 27
Pathogenic Aβ generation in familial Alzheimer’s disease: novel mechanistic insights and therapeutic implications
Trambauer, J., Fukumori, A., & Steiner, H. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.01.011 · Cited by 28
Promoting Long‐Term Cultivation of Motor Neurons for 3D Neuromuscular Junction Formation of 3D In Vitro Using Central‐Nervous‐Tissue‐Derived Bioink
Kong, J. S., Huang, X., Choi, Y., Yi, H., Kang, J.-S., Kim, S., Kim, J., Lee, H., Rim, Y. A., Ju, J. H., et al. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100581 · Cited by 28
Advances in Modeling Alzheimer's Disease In Vitro
Sharma, N. S., Karan, A., Lee, D.-H., Yan, Z., & Xie, J. (2021) · Advanced NanoBiomed Research · doi:10.1002/anbr.202100097 · Cited by 31
Dysfunction of vesicular storage in young-onset Parkinson's patient-derived dopaminergic neurons and organoids revealed by single cell electrochemical cytometry
Zhu, W., Tao, M., Hong, Y., Wu, S., Chu, C., Zheng, Z., Han, X., Zhu, Q., Xu, M., Ewing, A. G., et al. (2022) · Chemical Science · doi:10.1039/d2sc00809b · Cited by 28
Cerebral Organoids as an Experimental Platform for Human Neurogenomics
Nowakowski, T. J., & Salama, S. R. (2022) · Cells · doi:10.3390/cells11182803 · Cited by 27
Altered O-GlcNAcylation and mitochondrial dysfunction, a molecular link between brain glucose dysregulation and sporadic Alzheimer’s disease
Huang, C., Rust, N. C., Wu, H., & Hart, G. W. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.354515 · Cited by 28
Alzheimer’s Disease Treatment: The Search for a Breakthrough
Reiss, A. B., Muhieddine, D., Jacob, B., Mesbah, M., Pinkhasov, A., Gomolin, I. H., Stecker, M. M., Wısnıewskı, T., & Leon, J. D. (2023) · Medicina · doi:10.3390/medicina59061084 · Cited by 31
Co-Culture Models: Key Players in In Vitro Neurotoxicity, Neurodegeneration and BBB Modeling Studies
Monteiro, A. R., Barbosa, D. J., Remião, F., & Silva, R. (2024) · Biomedicines · doi:10.3390/biomedicines12030626 · Cited by 27
Upregulated ECM genes and increased synaptic activity in Parkinson’s human DA neurons with PINK1/ PRKN mutations
Tripathi, U., Rosh, I., Ezer, R. B., Nayak, R., Hussein, Y., Choudhary, A., Djamus, J., Manole, A., Houlden, H., Gage, F. H., et al. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00715-0 · Cited by 34
A guide for blood–brain barrier models
Soliman, Y., Al‐khodor, J., Koken, G. Y., & Mustafaoğlu, N. (2024) · FEBS Letters · doi:10.1002/1873-3468.15053 · Cited by 30
The Role of Chronic Inflammatory Bone and Joint Disorders in the Pathogenesis and Progression of Alzheimer's Disease
Culibrk, R. A., & Hahn, M. S. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.583884 · Cited by 28
Basic and Preclinical Research for Personalized Medicine
Lattanzi, W., Ripoli, C., Greco, V., Barba, M., Iavarone, F., Minucci, A., Urbani, A., Grassi, C., & Parolini, O. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11050354 · Cited by 30
The role of mycotoxins in neurodegenerative diseases: current state of the art and future perspectives of research
Nguyen, V. T. T., König, S., Eggert, S., Endres, K., & Kins, S. (2021) · Biological Chemistry · doi:10.1515/hsz-2021-0214 · Cited by 28
Distinct Effects of the Hippocampal Transplantation of Neural and Mesenchymal Stem Cells in a Transgenic Model of Alzheimer’s Disease
Campos, H. C., Ribeiro, D. E., Hashiguchi, D., Hukuda, D. Y., Gimenes, C., Romariz, S. A. A., Ye, Q., Tang, Y., Ulrich, H., & Longo, B. M. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10321-9 · Cited by 28
Cannabinoids Reduce Extracellular Vesicle Release from HIV-1 Infected Myeloid Cells and Inhibit Viral Transcription
DeMarino, C., Cowen, M., Khatkar, P., Cotto, B., Branscome, H., Kim, Y., Sharif, S. A., Agbottah, E. T., Zhou, W., Costiniuk, C. T., et al. (2022) · Cells · doi:10.3390/cells11040723 · Cited by 27
Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease
Cuní‐López, C., Stewart, R., Oikari, L. E., Nguyen, T. H., Roberts, T. L., Sun, Y., Guo, C. C., Lupton, M. K., White, A. R., & Quek, H. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03037-3 · Cited by 28
Organelle mapping in dendrites of human iPSC-derived neurons reveals dynamic functional dendritic Golgi structures
Wang, J., Daniszewski, M., Hao, M. M., Hernández, D., Pébay, A., Gleeson, P. A., & Fourrière, L. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112709 · Cited by 28
Alzheimer's Disease: Many Failed Trials, So Where Do We Go from Here?
Reiss, A. B., Glass, A. D., Wısnıewskı, T., Wolozin, B. L., Gomolin, I. H., Pinkhasov, A., Leon, J. D., & Stecker, M. M. (2020) · Journal of Investigative Medicine · doi:10.1136/jim-2020-001297 · Cited by 26
Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer’s disease
Marei, H. E. S., Khan, M. U. A., & Hasan, A. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00504-2 · Cited by 27
3D bioengineered neural tissue generated from patient-derived iPSCs mimics time-dependent phenotypes and transcriptional features of Alzheimer’s disease
Lomoio, S., Pandey, R. S., Rouleau, N., Menicacci, B., Kim, W., Cantley, W. L., Haydon, P. G., Bennett, D. A., Young-Pearse, T. L., Carter, G. W., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02147-3 · Cited by 25
Pathogenesis of miR-155 on nonmodifiable and modifiable risk factors in Alzheimer’s disease
Liu, J.-J., Long, Y.-F., Xu, P., Guo, H.-D., & Cui, G.-H. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01264-z · Cited by 26
Integrative pathway analysis across humans and 3D cellular models identifies the p38 MAPK-MK2 axis as a therapeutic target for Alzheimer’s disease
Yeganeh, P. N., Kwak, S. S., Jorfi, M., Koler, K., Kalatturu, T., von Maydell, D. K., Liu, Z., Guo, K., Choi, Y., Park, J., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.10.029 · Cited by 24
The Interface of Gene Editing with Regenerative Medicine
Farag, V., Devey, E. A., & Leong, K. W. (2024) · Engineering · doi:10.1016/j.eng.2024.10.019 · Cited by 30
Synthetic gene circuits as tools for drug discovery
Beitz, A. M., Oakes, C. G., & Galloway, K. E. (2021) · Trends in biotechnology · doi:10.1016/j.tibtech.2021.06.007 · Cited by 25
The role of FUT8 ‐catalyzed core fucosylation in Alzheimer's amyloid‐β oligomer‐induced activation of human microglia
Jin, L., Lucente, J. D., Mendiola, U. R., Tang, X., Zivkovic, A. M., Lebrilla, C. B., & Maezawa, I. (2023) · Glia · doi:10.1002/glia.24345 · Cited by 24
Comprehensive Bibliometric Analysis of Stem Cell Research in Alzheimer’s Disease from 2004 to 2022
Wang, R., Zhu, Y., Qin, L.-F., Xu, Z., Gao, X.-R., Liu, C., Xu, G., & Chen, Y. (2023) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000528886 · Cited by 24
Molecular Insights into Cell Type-specific Roles in Alzheimer’s Disease: Human Induced Pluripotent Stem Cell-based Disease Modelling
Qu, W., Canoll, P., & Hargus, G. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2022.05.006 · Cited by 24
Amyloid beta peptides (Aβ) from Alzheimer's disease neuronal secretome induce endothelial activation in a human cerebral microvessel model
Shin, Y. J., Evitts, K. M., Jin, S., Howard, C. C., Sharp-Milgrom, M., Schwarze‐Taufiq, T. A., Kinoshita, C., Young, J. E., & Zheng, Y. Y. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106125 · Cited by 25
Chitosan/PLA-loaded Magnesium oxide nanocomposite to attenuate oxidative stress, neuroinflammation and neurotoxicity in rat models of Alzheimer's disease
Rajkumar, M., Govindaraj, P., Vimala, K., Thangaraj, R., & Kannan, S. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01336-x · Cited by 23
Basic models to advanced systems: harnessing the power of organoids-based microphysiological models of the human brain
Boylin, K., Aquino, G. V., Purdon, M., Abedi, K., Kasendra, M. J., & Barrile, R. (2024) · Biofabrication · doi:10.1088/1758-5090/ad4c08 · Cited by 21
Cerebral Organoids and Antisense Oligonucleotide Therapeutics: Challenges and Opportunities
Lange, J., Zhou, H., & McTague, A. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.941528 · Cited by 22
Low glucose induced Alzheimer's disease‐like biochemical changes in human induced pluripotent stem cell‐derived neurons is due to dysregulated O‐GlcNAcylation
Huang, C., Rust, N. C., Wu, H., Yin, A., Zeltner, N., Yin, H., & Hart, G. W. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13058 · Cited by 21
Baseline Clinical and Biomarker Characteristics of Biobank Innovations for Chronic Cerebrovascular Disease With Alzheimer’s Disease Study: BICWALZS
Roh, H. W., Kim, N., Lee, D. A., Cheong, J. Y., Seo, S. W., Choi, S. H., Kim, E., Cho, S. H., Kim, B. C., Kim, S. Y., et al. (2022) · Psychiatry Investigation · doi:10.30773/pi.2021.0335 · Cited by 21
Patient-Derived Fibroblasts With Presenilin-1 Mutations, That Model Aspects of Alzheimer’s Disease Pathology, Constitute a Potential Object for Early Diagnosis
López-Toledo, G., Silva‐Lucero, M., Herrera‐Díaz, J., García, D.-E., Arias‐Montaño, J., & Cárdenas‐Aguayo, M. D. C. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.921573 · Cited by 20
Roles of Siglecs in neurodegenerative diseases
Siew, J. J., Chern, Y., Khoo, K., & Angata, T. (2022) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2022.101141 · Cited by 20
Stem Cell-Derived Neurons as Cellular Models of Sporadic Alzheimer’s Disease
Foveau, B., Correia, A. S., Hébert, S. S., Rainone, S., Potvin, O., Kergoat, M., Belleville, S., Duchesne, S., & LeBlanc, A. C. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180833 · Cited by 21
Current Status and Challenges of Stem Cell Treatment for Alzheimer’s Disease
Pacheco‐Herrero, M., Soto-Rojas, L. O., Reyes-Sabater, H., Garcés‐Ramírez, L., de la Cruz‐López, F., Villanueva‐Fierro, I., & Luna‐Muñoz, J. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200863 · Cited by 23
Cell-based regenerative and rejuvenation strategies for treating neurodegenerative diseases
Deng, S., Xie, H., & Xie, B. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04285-7 · Cited by 24
Genetically encoded sensors enable micro- and nano-scopic decoding of transmission in healthy and diseased brains
Lin, L., Gupta, S. N., Zheng, W., Si, K., & Zhu, J. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00960-8 · Cited by 20
Pinpointing the locus of GABAergic vulnerability in Alzheimer’s disease
Melgosa-Ecenarro, L., Doostdar, N., Radulescu, C. I., Jackson, J., & Barnes, S. J. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.06.017 · Cited by 20
Retinal organoids from human-induced pluripotent stem cells: From studying retinal dystrophies to early diagnosis of Alzheimer’s and Parkinson’s disease
Móvio, M. I., de Lima-Vasconcellos, T. H., dos Santos, G. B., Echeverry, M. B., Colombo, E., Mattos, L. S., Resende, R. R., & Kihara, A. H. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.09.011 · Cited by 21
Recent Advances in Microglia Modelling to Address Translational Outcomes in Neurodegenerative Diseases
Cuní‐López, C., Stewart, R., Quek, H., & White, A. R. (2022) · Cells · doi:10.3390/cells11101662 · Cited by 19
Functionalized Nanodiamonds for Targeted Neuronal Electromagnetic Signal Detection
Costa, B. N. L., Camarneiro, F., Marote, A., Barbosa, C., Vedor, C., Tomé, D., Costa, F. J., Dias, M. S., Correia, J., Pires, J. P., et al. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c12462 · Cited by 19
Brain organoid models for studying the function of iPSC-derived microglia in neurodegeneration and brain tumours
Sabogal-Guáqueta, A. M., Mitchell-Garcia, T., Hunneman, J., Voshart, D. C., Thiruvalluvan, A., Foijer, F., Kruyt, F. A. E., Trombetta-Lima, M., Eggen, B. J. L., Boddeke, E., et al. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106742 · Cited by 19
Efficient manipulation of gene dosage in human iPSCs using CRISPR/Cas9 nickases
Tao, Y., Duan, Y., Tsang, H. W. S., Xu, H. J., Chen, Y., Cao, H., Chen, Y., Fu, A. K. Y., & Ip, N. Y. (2021) · Communications Biology · doi:10.1038/s42003-021-01722-0 · Cited by 21
Protein aggregation and neurodegenerative disease: Structural outlook for the novel therapeutics
Arar, S. H., Haque, M. A., & Kayed, R. (2023) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26561 · Cited by 20
Three-dimensional bioprinting healthy and diseased models of the brain tissue using stem cells
Walus, K., Beyer, S., & Willerth, S. M. (2020) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2020.03.002 · Cited by 19
Evaluation of a Selective Chemical Probe Validates That CK2 Mediates Neuroinflammation in a Human Induced Pluripotent Stem Cell-Derived Microglial Model
Mishra, S., Kinoshita, C., Axtman, A. D., & Young, J. E. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.824956 · Cited by 16
Analyzing alternative splicing in Alzheimer’s disease postmortem brain: a cell-level perspective
Farhadieh, M., & Ghaedi, K. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1237874 · Cited by 18
Astrocytes Derived from Familial and Sporadic Alzheimer’s Disease iPSCs Show Altered Calcium Signaling and Respond Differently to Misfolded Protein Tau
Brezováková, V., Syková, E., & Jadhav, S. (2022) · Cells · doi:10.3390/cells11091429 · Cited by 19
P97/VCP ATPase inhibitors can rescue p97 mutation-linked motor neuron degeneration
Wang, F., Li, S., Wang, T. Y., Lopez, G. A., Antoshechkin, I. A., & Chou, T. (2022) · Brain Communications · doi:10.1093/braincomms/fcac176 · Cited by 18
Cortical spheroid on perfusable microvascular network in a microfluidic device
Russell, T. A., Dirar, Q., Li, Y., Chiang, C., Laskowitz, D. T., & Yun, Y. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288025 · Cited by 18
Optogenetic and chemogenetic approaches for modeling neurological disorders in vivo
Krut’, V. G., Kalinichenko, A. L., Maltsev, D. I., Jappy, D., Shevchenko, E. K., Podgorny, O. V., & Belousov, V. V. (2024) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2024.102600 · Cited by 17
Microphysiological Systems for Neurodegenerative Diseases in Central Nervous System
Bae, M., Yi, H., Jang, J., & Cho, D. (2020) · Micromachines · doi:10.3390/mi11090855 · Cited by 19
Analyzing Olfactory Neuron Precursors Non-Invasively Isolated through NADH FLIM as a Potential Tool to Study Oxidative Stress in Alzheimer’s Disease
Gomez‐Virgilio, L., Luarte, A., Ponce, D. P., Bruna, B., & Behrens, M. I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126311 · Cited by 18
Alzheimer’s Disease: Current Perspectives and Advances in Physiological Modeling
Boder, E. J., & Banerjee, I. A. (2021) · Bioengineering · doi:10.3390/bioengineering8120211 · Cited by 18
Engineered nanoparticles for the treatment of Alzheimer’s disease
Jia, J., Zhao, S., Zhao, J., & Gao, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1510798 · Cited by 24
Toward Studying Cognition in a Dish
Rouleau, N., Murugan, N. J., & Kaplan, D. L. (2021) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2021.01.005 · Cited by 19
Cell models for Down syndrome-Alzheimer’s disease research
Wu, Y., West, N. R., Bhattacharyya, A., & Wiseman, F. K. (2022) · Neuronal Signaling · doi:10.1042/ns20210054 · Cited by 17
Aberrant Retinal Pigment Epithelial Cells Derived from Induced Pluripotent Stem Cells of a Retinitis Pigmentosa Patient with the PRPF6 Mutation
Liang, Y., Tan, F., Sun, X., Cui, Z., Gu, J., Mao, S., Chan, H. F., Tang, S., & Chen, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169049 · Cited by 17
Electrically Copolymerized Polydopamine Melanin/Poly(3,4-ethylenedioxythiophene) Applied for Bioactive Multimodal Neural Interfaces with Induced Pluripotent Stem Cell-Derived Neurons
Huang, W.-C., Hung, C.-H., Lin, Y.-W., Zheng, Y.-C., Lei, W., & Lu, H. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00822 · Cited by 17
Modelling Alzheimer's disease using human brain organoids: current progress and challenges
Yanakiev, M., Soper, O., Berg, D. A., & Kang, E. (2022) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2022.40 · Cited by 17
Stem cells in the treatment of Alzheimer's disease – Promises and pitfalls
Bhatti, J. S., Khullar, N., Mishra, J., Kaur, S., Sehrawat, A., Sharma, E., Bhatti, G. K., Selman, A., & Reddy, P. H. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166712 · Cited by 19
Tackling neurodegeneration in vitro with omics: a path towards new targets and drugs
Carraro, C., Montgomery, J. V., Klimmt, J., Paquet, D., Schultze, J. L., & Beyer, M. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1414886 · Cited by 16
Unlocking the therapeutic potential: odyssey of induced pluripotent stem cells in precision cell therapies
Mohite, P. B., Puri, A. V., Dave, R., Budar, A., Munde, S. V., Ghosh, S. B., Alqahtani, T., Shmrany, H. A., Kumer, A., & Dhara, B. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000001892 · Cited by 20
Challenges in Physiological Phenotyping of hiPSC-Derived Neurons: From 2D Cultures to 3D Brain Organoids
Mateos‐Aparicio, P., Bello, S. A., & Moreno, A. R. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00797 · Cited by 20
Contraction Control of Aligned Myofiber Sheet Tissue by Parallel Oriented Induced Pluripotent Stem Cell-Derived Neurons
Takahashi, H., Oikawa, F., Takeda, N., & Shimizu, T. (2022) · Tissue Engineering Part A · doi:10.1089/ten.tea.2021.0202 · Cited by 16
Astrocytes Drive Divergent Metabolic Gene Expression in Humans and Chimpanzees
Zintel, T. M., Pizzollo, J., Claypool, C. G., & Babbitt, C. C. (2023) · Genome Biology and Evolution · doi:10.1093/gbe/evad239 · Cited by 18
β-Amyloid peptide modulates peripheral immune responses and neuroinflammation in rats
Adhikary, K., Mohanty, S., Bandyopadhyay, B., Maiti, R., Bhattacharya, K., & Karak, P. (2024) · BioMolecular Concepts · doi:10.1515/bmc-2022-0042 · Cited by 16
Olive Oil Industry By-Products as a Novel Source of Biophenols with a Promising Role in Alzheimer Disease Prevention
Gonçalves, M., Costa, M., Paiva‐Martins, F., & Silva, P. (2024) · Molecules · doi:10.3390/molecules29204841 · Cited by 17
Gene Editing and Alzheimer's Disease: Is There Light at the End of the Tunnel?
Stepanichev, M. Y. (2020) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.00004 · Cited by 17
Human Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology
Kühn, R., Mahajan, A., Canoll, P., & Hargus, G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.766773 · Cited by 18
Endotype reversal as a novel strategy for screening drugs targeting familial Alzheimer's disease
Caldwell, A. B., Liu, Q., Zhang, C. M., Schroth, G. P., Galasko, D. R., Rynearson, K. D., Tanzi, R. E., Yuan, S. H., Wagner, S. L., & Subramaniam, S. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12553 · Cited by 16
Experimental modelling of Alzheimer's disease for therapeutic screening
Blaikie, L., Kay, G., Maciel, P., & Lin, P. K. T. (2022) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2022.100044 · Cited by 16
Profiling biomanufactured extracellular vesicles of human forebrain spheroids in a Vertical‐Wheel Bioreactor
Liu, C., Sun, L. J., Worden, H., Ene, J., Zeng, O. Z., Bhagu, J., Grant, S. C., Bao, X., Jung, S., & Li, Y. (2024) · Journal of Extracellular Biology · doi:10.1002/jex2.70002 · Cited by 16
Selenium promotes neural development through the regulation of GPX4 and SEPP1 in an iPSC-derived neuronal model
Dai, Z., Yu, Y., Chen, R., Zhu, H., Fong, H., Kuang, J., Jiang, Y., Chen, Y., Niu, Y., Chen, T., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.123011 · Cited by 18
Retroviral infection of human neurospheres and use of stem Cell EVs to repair cellular damage
Branscome, H., Khatkar, P., Sharif, S. A., Yin, D., Jacob, S., Cowen, M., Kim, Y., Erickson, J. W., Brantner, C. A., El‐Hage, N., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-05848-x · Cited by 15
Histone post-translational modification and heterochromatin alterations in neurodegeneration: revealing novel disease pathways and potential therapeutics
Fisher, R. M. A., & Torrente, M. P. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1456052 · Cited by 18
Induced Pluripotent Stem Cells-Based Regenerative Therapies in Treating Human Aging-Related Functional Decline and Diseases
Yu, P., Liu, B., Dong, C., & Chang, Y. (2025) · Cells · doi:10.3390/cells14080619 · Cited by 19
Flexible and Accurate Substrate Processing with Distinct Presenilin/γ-Secretases in Human Cortical Neurons
Watanabe, H., Imaizumi, K., Cai, T., Zhou, Z., Tomita, T., & Okano, H. (2021) · eNeuro · doi:10.1523/eneuro.0500-20.2021 · Cited by 15
Detection and Functional Evaluation of the P2X7 Receptor in hiPSC Derived Neurons and Microglia-Like Cells
Francistiová, L., Vörös, K., Lovász, Z., Dinnyés, A., & Kobolák, J. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.793769 · Cited by 14
Induced Pluripotent Stem Cells: Hope in the Treatment of Diseases, including Muscular Dystrophies
Beghini, D. G., Horita, S. I. M., Cascabulho, C. M., Alves, L. A., & Henriques‐Pons, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155467 · Cited by 22
Research models to study lewy body dementia
Boschen, S. L., Mukerjee, A. A., Faroqi, A. H., Rabichow, B. E., & Fryer, J. D. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00837-w · Cited by 16
In Vitro Models of Amyotrophic Lateral Sclerosis
Zhou, L., Chen, W., Jiang, S., & Xu, R. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01423-8 · Cited by 13
Fabrication approaches for high-throughput and biomimetic disease modeling
Grubb, M., & Caliari, S. R. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.03.006 · Cited by 15
Intranasally Administered L-Myc-Immortalized Human Neural Stem Cells Migrate to Primary and Distal Sites of Damage after Cortical Impact and Enhance Spatial Learning
Gutova, M., B, J. P. C. A., Adhikarla, V., Tsaturyan, L., Barish, M. E., Rockne, R. C., Moschonas, E. H., Bondi, C. O., & Kline, A. E. (2021) · Stem Cells International · doi:10.1155/2021/5549381 · Cited by 14
3D Printing for Neural Repair: Bridging the Gap in Regenerative Medicine
Clair‐Glover, M. S., Yue, Z., & Dottori, M. (2025) · Advanced Materials · doi:10.1002/adma.202507590 · Cited by 14
Transcriptome-Powered Pluripotent Stem Cell Differentiation for Regenerative Medicine
Ogi, D. A., & Jin, S. (2023) · Cells · doi:10.3390/cells12101442 · Cited by 13
Isolation, phytochemistry, characterization, biological activity, and application of Morinda officinalis How oligosaccharide: a review
Yue, J., Xia, W., Wang, Y., Zhang, Y., Zhang, Y., Li, Y., Wang, L., Li, C., Li, T., & Fu, X. (2023) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgad096 · Cited by 12

Authors: Penney, J., Ralvenius, W. T., & Tsai, L.-H.
Affiliations: Massachusetts Institute of Technology (US)
Corresponding author: Tsai, Li-Huei
ORCID: Penney, Jay
Ralvenius, William T.
Tsai, Li-Huei
Venue: Molecular Psychiatry
Publisher: Springer Science and Business Media LLC
Published: 2019-08-07
Volume: 25
Issue: 1
Pages: 148-167
ISSN: 1359-4184 (ISSN-L)
1476-5578
DOI: 10.1038/s41380-019-0468-3
PMC: PMC6906186
OpenAlex: W2964627277
Cited by: 471
References: 235
Citations by year: 2026: 54 · 2025: 66 · 2024: 78 · 2023: 84 · 2022: 77 · 2021: 65 · 2020: 41 · 2019: 6
FWCI: 4.18
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0 (tdm)
creativecommons.org/licenses/by/4.0 (vor)
Locations: Molecular Psychiatry (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
IslandScholar (University of Prince Edward Island) (submittedVersion)
Funders: National Science Foundation
Cure Alzheimer's Fund
Robert A. and Renee E. Belfer Family Foundation
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (177920)
National Institutes of Health (NS051874)
National Institute on Aging (RF1AG054012)
National Institute of Neurological Disorders and Stroke (R37NS051874)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
Keywords: Alzheimer's disease, induced pluripotent stem cells, neurodegeneration, co-culture model, disease modeling, genome editing, Alzheimer's disease risk genes, preclinical research
MeSH terms: Alzheimer Disease, Brain, Cell Differentiation, Humans, Models, Biological, Neurons, Neurodegenerative Diseases, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Modeling Alzheimer’s disease with iPSC-derived brain cells

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks